Medium chain Triglycerides Market Overview
Product Overview and Scope of Medium chain Triglycerides
Medium-chain triglycerides (MCTs) are dietary supplements and are consumed with medications to treat food absorption disorders such as diarrhea, steatorrhea, and liver disease. It has played an important role in reducing inflammation, lowering weight, and decreasing metabolic syndrome and abdominal obesity. Medium-chain triglycerides (MCTs) are triglycerides composed of three fatty acids with a glycerol backbone and an aliphatic tail of 6-12 carbon atoms. According to the U.S. Department of Agriculture's National Nutrition Database, MCTs are found naturally in foods, with high percentages in coconut oil, palm kernel oil, chopped coconut, and raw coconut meat.
The MCT is used for obesity, improving athletic performance, Alzheimer’s disease, and many medical other conditions. It is also fighting bacterial growth and helps in managing certain neurological conditions. This oil has become popular among athletes and bodybuilders as a good source of supplement options. On the other hand, MCT oil has 10% fewer calories than long-chain triglycerides (LCTs), which are found in foods such as nuts, olive oil, and avocados. The body absorbs MCTs more quickly than long-chain triglycerides (LCTs) which consist of more carbons in their fatty acid chains.
Medium chain Triglycerides Market – Global Industry Analysis
Market Drivers
- Growing awareness about healthy food
Growing awareness about healthy food is fueling the growth of the medium-chain triglycerides market. In recent years, the public health practice has expanded the scope of MCT to promote sustainable health and nutrition. So proper eating habits and the nutritional value of the foods consumed are becoming increasingly important areas for the prevention of diseases worldwide. Adequate and proper nutrition is an important aspect of a healthy lifestyle. Therefore, there is a need to increase awareness of the role of nutrients contained in food in the maintenance, growth, reproduction, health, and disease prevention of the human body.
Healthy food habits are important in many aspects including proper cardiovascular function, respiratory ventilation, muscle strength, protection from infection, and mental health. In addition, it can prevent nutrition-related diseases through a diet that includes sufficient amounts of food components such as carbohydrates, proteins, fats, vitamins, minerals, and water that are responsible for bodybuilding and good immunity and energy supply.
- Increasing demand for cosmetic products to enhance skin textures
- Growing popularity of sports nutrition
Global Medium chain Triglycerides Revenue by Regions (2018-2023)
Global Medium chain Triglycerides Revenue and Market Share (%) by Regions (2018-2023)
Global Medium chain Triglycerides Revenue (USD Billion) by regions (2018-2023)
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
|
|
North America |
XX |
XX |
XX |
XX |
XX |
XX |
|
Europe |
XX |
XX |
XX |
XX |
XX |
XX |
|
Asia Pacific |
XX |
XX |
XX |
XX |
XX |
XX |
|
Latin America |
XX |
XX |
XX |
XX |
XX |
XX |
|
Middle East & Africa |
XX |
XX |
XX |
XX |
XX |
XX |
|
Total |
XX |
XX |
XX |
1.27 |
XX |
XX |
Global Medium chain Triglycerides market was valued at USD 1.27 Billion, in 2022 and is expected to grow at a CAGR of CAGR 6.8% over the forecast period, from 2023 to 2030.
Medium chain Triglycerides Market Segmentation:
By Form
- Dry
- Liquid
By Source
- Palm
- Coconut
- Others (Milk and vegetable fats)
By fatty acid type
- Caproic Acid
- Caprylic Acid
- Lauric Acid
- Capric Acid
By Application
- Dietary & Health Supplements
- Personal Care & Cosmetics
- Pharmaceuticals
- Others
Global Medium chain Triglycerides Manufacturers Profiles/Analysis
Croda International Plc
Croda International Plc Company Basic Information and Sales Area
|
|
Item |
Description |
|
1 |
Company Name |
Croda International Plc |
|
2 |
Website |
www.croda.com |
|
3 |
Established Date |
1925 |
|
4 |
Headquartered |
United Kingdom |
|
5 |
Market Position/History |
Croda International Plc was founded in 1925 by Mr. Crowe, and a chemist, Mr. Dawe. The company has over 6,100 employees working in manufacturing sites, laboratories, and offices across the world. In 1997, it has completed the acquisition of Sederma which brought the company new capabilities in skincare active ingredients. It acquired Uniqema from ICI in 2006, which established the company as a leader, and strengthened manufacturing capabilities with additional sites in Europe and Asia. In years 2019 and 2020, the company brought two significant acquisitions that added new expertise to its Health Care Business: Biosector and Avanti Polar Lipids. The company operates in 37 countries worldwide. |
|
6 |
Sales Area |
Worldwide |
|
7 |
Contact Number |
Cowick Hall, Snaith Goole, East Yorkshire DN14 9AA, United Kingdom Tel: +44 (0) 1405 860551 |
Business Segment/ Overview:
Croda International Plc is a United Kingdom-based chemical company. The company operates through several segments such as consumer care, life sciences, performance technologies, and industrial chemicals.
Consumer care produces specialty and active ingredients for cosmetics and skincare/haircare and also flavors and fragrances. The life sciences business manufactures products for healthcare and agrochemicals. Its performance technologies segment provides Smart Materials and Energy Technologies. Further, industrial chemicals produce additives for industrial products and by-products from other businesses. Croda International Plc owns several brands including Alban Muller, Croda, Crodarom, Iberchem, Parfex, and Sederma.
Recent Developments:
|
Year |
Latest News |
|
February 2023 |
Croda International Plc completed the acquisition of Solus Biotech and expands its fast growth Beauty Actives business in Asia
Croda International Plc announced the acquisition of Solus Biotech (‘Solus’). This acquisition provides access to Solus’ existing biotech-derived ceramide and phospholipid technologies and its emerging capabilities in natural retinol. This will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted segments. Solus expands Croda’s Asian manufacturing capability and will create a new biotechnology R&D hub in the region. |
Business Strategy
Croda International Plc is driving growth through sustainability and innovation. For instance, it has acquired Avanti and Iberchem. The acquisition of Avanti is strengthening its Life Sciences segment by providing a new channel to market Croda’s ingredients for early-stage pharmaceutical research in both commercial and academic organizations worldwide and the acquisition of Iberchem expands its reach into the high-growth fragrances market. The company is expanding its portfolio offerings through strategic acquisitions and partnerships. It has acquired Solus Biotech to expand fast growth Beauty Actives business in Asia. Moreover, the Life Sciences segment focuses on leveraging in-house developed and acquired technologies, building further scale to deliver customers’ drug, vaccine, and crop science products.
